Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Diagnostic yield of whole genome sequencing after non-diagnostic exome sequencing or gene panel in developmental and epileptic encephalopathies
Author: Palmer, E.E.
Sachdev, R.
Macintosh, R.
Genetic Counselling, G.D.
Melo, U.S.
Mundlos, S.
Righetti, S.
Kandula, T.
Minoche, A.E.
Puttick, C.
Gayevskiy, V.
Hesson, L.
Idrisoglu, S.
Shoubridge, C.
Thai, M.H.N.
Davis, R.L.
Drew, A.P.
Sampaio, H.
Andrews, P.I.
Lawson, J.
et al.
Citation: Neurology, 2021; 96(13):e1770-e1782
Publisher: American Academy of Neurology
Issue Date: 2021
ISSN: 0028-3878
Statement of
Elizabeth Emma Palmer, Rani Sachdev, Rebecca Macintosh, Uirá Souto Melo, Stefan Mundlos, Sarah Righetti ... et al.
Abstract: OBJECTIVE: To assess the benefits and limitations of whole genome sequencing (WGS) compared to exome sequencing (ES) or multigene panel (MGP) in the molecular diagnosis of developmental and epileptic encephalopathies (DEE). METHODS: We performed WGS of 30 comprehensively phenotyped DEE patient trios that were undiagnosed after first-tier testing, including chromosomal microarray (CMA), and either research ES (n=15) or diagnostic MGP (n=15). RESULTS: 8 diagnoses were made in the 15 individuals who received prior ES (53%): 3 individuals had complex structural variants; 5 had ES-detectable variants which now had additional evidence for pathogenicity. 11 diagnoses were made in the 15 MGP-negative individuals (68%); the majority (n=10) involved genes not included in the panel, particularly in individuals with post-neonatal onset of seizures and those with more complex presentations including movement disorders, dysmorphic features and/or multi-organ involvement. 42% of diagnoses were autosomal recessive or X-chromosome linked. CONCLUSION: WGS was able to improve diagnostic yield over ES primarily through the detection of complex structural variants (n=3). The higher diagnostic yield was otherwise better attributed to the power of re-analysis rather than inherent advantages of the WGS platform. Additional research is required to assist in the assessment of pathogenicity of novel non-coding and complex structural variants and further improve diagnostic yield for patients with DEE and other neurogenetic disorders.
Keywords: Chromosomes, Human, X
Spasms, Infantile
Nerve Tissue Proteins
Child, Preschool
Chromosome Inversion
Pathology, Molecular
Rho Guanine Nucleotide Exchange Factors
MEF2 Transcription Factors
Whole Genome Sequencing
Exome Sequencing
Description: First published February 10, 2021
Rights: © 2021 American Academy of Neurology.
DOI: 10.1212/WNL.0000000000011655
Grant ID:
Published version:
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.